The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.

Full Abstract

BACKGROUND: Septic shock is associated with vasopressin deficiency and hypersensitivity to its exogenous administration. The aim of this study is to review the 28-day survival rate, hemodynamic and renal effects of vasopressin therapy in refractory septic shock Japanese patients. METHODS: 55 Japanese patients experiencing catecholamine-resistant septic shock were treated with vasopressin. Hemodynamic alterations and the serum concentrations of aspartate aminotransferase, total bilirubin and creatinine clearance were evaluated following vasopressin treatment. RESULTS: In both, survivors and non-surviving patients, treatment with vasopressin resulted in a significantly increase in mean arterial pressure, hourly urine output, and a significant decrease in heart rate and total pressor dosage requirements. Creatinine clearance was significantly increased only in survivors. There were no significant changes in the serum concentrations of aspartate aminotransferase and total bilirubin. The 28-day survival rate was 45% (25 patients). CONCLUSIONS: In Japanese septic shock patients, vasopressin infusion improved hemodynamic status and reduced catecholamine requirement, and 28-day survival rate was 45%.

Author information

Author/s: Sawa, N (N); Ubara, Y (Y); Katori, H (H); Hoshino, J (J); Suwabe, T (T); Takemoto, F (F); Uchida, N (N); Masuoka, K (K); Wake, A (A); Taniguchi, S (S); Takaichi, K (K);

Affiliation: Departments of Nephrology, Toranomon Hospital, Tokyo, Japan. naokis(-atsign-)toranomon.gr.jp

Journal and publication information

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal: Clinical nephrology (Clin Nephrol), published in Germany. (Language: eng)

Reference: 2009-Aug; vol 72 (issue 2) : pp 129-36

Dates: Created 2009/07/30; Completed 2009/10/27;

PMID: 19640370, status: MEDLINE (last retrieval date: 10/27/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.